GEOGRAPHIC ATROPHY

Slow progression. Careful monitoring. Informed choices.

Geographic atrophy on near-infrared autofluorescence and OCT

Geographic atrophy on near-infrared autofluorescence (NI-AF) and OCT imaging. Geographic atrophy isolated to fovea (panel A) and involving perifoveal region (panel B). Credit: PMC5193230 (CC-BY license).

What You Should Know

  • Geographic atrophy (GA) is advanced dry AMD—a slow, progressive condition.
  • Everyone progresses differently; regular monitoring is essential.
  • Most patients benefit from close observation without treatment.
  • Treatment options exist but involve injections and carry wet AMD risk.
  • Vision support and low-vision aids help maintain independence.

What is Geographic Atrophy?

Geographic atrophy (GA) is advanced dry macular degeneration where patches of the retina gradually wear away, affecting your central vision. It’s not painful and doesn’t cause complete blindness, but it can make reading, driving, and recognizing faces harder over time. The good news: GA progresses slowly, with plenty of time to monitor and plan. Everyone’s course is different—some progress rapidly, others slowly.

What Do I Do About It?

Monitoring is your first step. I’ll check your eyes with OCT and imaging every 3–6 months to track how your condition is changing. This tells us whether treatment makes sense for you.

Most patients benefit from observation alone. If your GA is growing slowly and hasn’t reached the center of your vision yet, watching closely without treatment is often the best approach.

If You Want to Slow Progression

Two FDA-approved injections (Syfovre or Izervay) can slow GA expansion. Both require monthly injections and carry a risk of triggering wet AMD—a more aggressive form that needs additional treatment. I monitor closely to catch any changes early. If wet AMD does appear, it can be managed with additional therapy.

Vision support matters. Low-vision aids (magnifiers, specialized lighting) help maintain independence if central vision is affected. AREDS2 supplements help if you have intermediate dry AMD without GA yet.

Looking Ahead

Researchers are exploring systemic complement inhibitors (pills or IV medications) that may offer simpler, more effective treatment in the future. This is an active area of research, and better options may be coming.

When to Contact Me

Call Promptly If:

  • You notice a new dark spot or blurriness in your central vision.
  • You experience distorted vision (straight lines appear wavy).
  • After an injection, you have eye pain, redness, or increased floaters.
  • Your vision declines more rapidly than expected.

Stay in touch if you’d like to discuss treatment, have concerns about your vision, or want to explore vision rehabilitation resources. Regular contact helps me keep your care personalized to your needs.


This page provides educational information. It is not a substitute for a comprehensive eye exam. Please schedule an appointment to discuss your individual situation.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top